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NVESTIGATORS” 
The association of smoking with coronary heart disease, 
lung disease, cancer, stroke and other health problems i
well established (23. The beneficial r:ffects of smoking 
cessation on survival nd incidence of m;rocardiai nfarction 
in populations without known coronary antery disease has 
also been described (4,5). Recent reports (6,7) from the 
nonrandomized Coronary Artery Surgery Study (CASS) 
registry have documented improved survival after smokir,g 
*A listing of principal and coigvestigators has been published previously 
(I). 
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cessation i patients with angiographica!Ely proved coronary 
artery disease who were followed up for as long as 6 years. 
However, the morbidity associated with cant; led smoking 
in patients with coronary artery disease isnot as extensively 
described and may, in fact, have a greater impact on society 
than the effects of smoking on survival. 
The purpose of the present study was to ascertain the 
effects of continued smoking and smoking cessation on 
survival and quality of life in patients with angiographicaliy 
documented coronary artery disease who were randomized 
to medical or surgical therapy in CASS and followed u 
for 10 years. Differences between smokers and non- 
smokers were assessed +virh respect te” amount of angina, 
activity limitation, hospital admissions, repeat coronary 
artery bypass urgery, myocardial infarction, stroke, peripb- 
era1 vascular surgery and employment. Additionally, an 
estimate was made of the minimal cost of additional health 
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ap;2ared to be a result of continued cigarette 
Study design. CA!%, a prospective randomized study 
that studied medical versus urgical treatment in Patients 
with am&graphically proved coronary artery disease, en- 
rolled patients at 15 clinical sites in the United States and 
Canada between 1974 and 1979 (8). Before the initiation of 
patient recruitment, the CASS protocol was approved by 
each institution’s committee on human research. Consecu- 
tive patients who underwent coronary angiography at these 
sites and who gave informed consent were entered into a 
registry (n = 24,959), and from this group 780 patients with 
70% diameter stenosis f OX or more operable vessels 
were randomly assigned to medical orsurgical treatment a
11 of the 15 sites, Randomized patients were 565 years old 
and had either I) Canadian Cardiovascular Society (9) class 
I or II angina, with or without a history of myocardial 
infarction, or 2) were asymptomatic after documented myo- 
cardial infarction >3 weeks before andomization. Exclu- 
sion criteria nd other details of the study design have been 
described previously (8). Each patient’s moking history 
was collected prospectively and included ata on whether 
cigarettes were smoked at baseline and ateach &month 
follow-up interval as well as an estimate ofthe average daily 
cigarette consumption (8). 
‘Treatment. Allpatients were treated for angina pectoris, 
arrhythmias, congestive heart failure and coronary disease 
risk factors according to treatment guidelines provided by 
the CASS Steering Committee (8). Patients randomly as- 
signed to surgical therapy underwent coronary revascular- 
ization. Patients assigned tomedical therapy became eligible 
for surgery if angina refractory to medical therapy devel- 
oped. 
Follow~up. Patient follow-up questionnaires (which in- 
cluded information regarding the number of cigarettes 
smoked before each follow-up evaluation) were adminis- 
tend at &month intervals for 10 years and physical exami- 
nations were performed at6, 18 and 60 months after enroll- 
ment. Patients were encouraged to undergo laboratory 
evaluations, including serum choiecterol determinations, at 
the time of each physical examination (8). 
R&ion of terms. Smoking srahs. A “smoker” was 
defined as a patient who smoked cigarettes at any time 
during the follow-up eriod, and a “nonsmoker’. asa patient 
who did not smoke cigarettes during follow-up. To assess the 
hpaCt of smoking cessation on survival, two additional 
definitions were used: a “quitter” was defined as a patient 
who was smoking at baseline but had stopped smoking at the 
1st dmonth follow-up evaluation; a “nonquitter” was a 
patient Who was smoking at baseline and at the 1st 6-month 
evaluation. To avoid the confounding problem of “mixed 
smoking behavior” (quitters who resumed smoking after the 
1st 6-month WdUatiOn or nonquitters who later stopped 
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smoking) affecting the survival data, tome-dependent Cox
survival analyses (10) were pe rmed as described under 
Statistical nalysis. 
Chestpain status. Each patient’s average or typic 
of chest discomfort during the 6 weeks before ntry into the 
study and during the intcrva? si:+ the last follow-up study 
was prospectively assessed accoi-\llng to the Canadian Car- 
diovascular Society classification (9). Chest pain unrelated 
to exertion was classified as class 1to II. 
Heart failure. If the patient reported ankle edema, dys- 
pnea or orthopnea, heart failure was considered to-be 
present. 
Acrivity li~aita~io~l. 
entry and during the int 
was classified as follow 
3) mild limitation, 4)mo 
or uncertain activity ii. 
or recovery from surgery. 
Employment status. Each patient’s employment status at 
entry and during follow-up was classified as follows: 
1) employed (either full-time or part-time), or 2) not 
ployed (left work before retirement age because of car 
symptoms orother easons). Homemakers and patients 
retired for nonmedical reasons were excluded tram the 
employment analyses. 
Left ventricular score. Bach patient’s left ve~t~cu~ogr~ 
was analyzed in the right anterior oblique view. Thecon- 
traction in each of five segments was scored as normal =I; 
moderate hypokinesia = 2; severe hypokinesia = 3; akinesia 
= 4; dyskinesia = 5; aneurysmal = 6. The total score was 
g the values assigned toeach segment. 
sis. For discrete variables, comparisons 
between smokers and nonsmokers were tested by a chi- 
square test. Continuous variables were compared by using a 
two-tailed Student t test of mean values. The number of 
hospita! admissions was compared between smoking and 
nonsmoking groups with the use of the normal approxima- 
tion to the difference between two Poisson random varia- 
bles. Cumulative mortality rates were estimated by the 
product-limit (Kaplan-Meier) method. Comparisons in sur- 
vival over time between smokers and nonsmokers were 
made with the log-rank statistic. Because smoking behavior 
varied over time in many patients, two “time-dependent” 
smoking variables were considered: 1) the average number 
of cigarettes smoked over follow-up to a given time, and 
2) the percent of time (up to a given follow-up interval) that 
the patient smoked. Survival among smokers ntering the 
study was modeled allowing any variable related to survival 
with p 5 0.1 to enter a step-up, step-wise Coxproportional 
hazards regression model. Variables considered in the model 
were age, gender, serum cholesterol level, use of a beta- 
adrenergic blocking agent, number of vessels diseased, left 
ventricular score, randomization to medical or surgical ther- 
apy, Can:yrian Cardiovascular Society angina class, history 
of prior ijyocardial infarction, percent lef main coronary 
artery stenosis and number of proximal vessels di eased. 
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Average age (yr) 
Gender, male 
Race, white 
Cholesterol ~250 mgldl 
Prior smoking history 
Current smoker 
Former smoker 
Never smoked 
History of diabetes 
Prior myocardial infarction 
Prior vascular disease 
IPeripheral arterial disease 
Cerebrovascular disease 
CAD 
I-Vessel 
%-Vessel 
=3-Vessel 
Ejection fraction (A) 
LV score 
Angina class 
No angina 
Class I or 11 angina 
Class 111 or IV angina 
Activity limitation 
None 
Intermediate-mild 
Moderate-severe 
U§C of medications 
Nitrates 
Beta-blockers 
Digoxin 
Diuretics 
Employed 
49 
281 
301 
87 
90.1 
96.5 
33.2 
53 
423 
466 
127 
9Q.4 
99.6 
32.3 
249 79.8 61 13 
61 19.6 282 60.3 
2 0.6 125 26.7 
23 7.4 43 9.2 
207 66.3 260 55.6 
0.37 
9.003 
30 IQ.1 33 7.2 0.16 
5 1.6 II 2.4 0.48 
89 
124 
99 
59. I 
7.46 
Il.9 
28.5 
39.7 
31.7 
125 
It14 
159 
61.7 
7.47 
11.6 
26.7 
39.3 
34 
76 
236 
0 
24.4 
75.6 
94 
374 
0 
88 
162 
198 
197 
204 
38 
82 
347 
20.1 
79.9 
43 13.8 
105 33.7 
164 52.6 
ig.8 
38.9 
42.3 
161 51.6 
134 42.9 
24 7.1 
31 111.9 
216 6g.3 
42.1 
43.6 
8.1 
17.5 
73.1 
____ - 
Smokers nonsmokers 
(n = 312) (n = 468) 
NO. % NO. % 8, Value 
CAD = coronary artery disease; LV = left ventricular; LVEDP = tell ventricular end-diastolic pressure. 
The two preceding time-dependent smoking covariates were 
then added to the model to ascertain f they had additional 
power for predicting survival. 
ysis. No prospective hospital cost data were 
obtained in CASS. The per diem cost of a hospital day was 
obtained from the American Hospital Association (1 I) and 
multiplied by the additional days that smokers were in the 
hospital. The product represents a minimal estimate of the 
increased cost of health care attributable to cigarette use. 
ne c eteris ). Of the 780 patients 
randomized tomedical therapy or coronary artery bypass 
graft surgery in CASS, 312 (40%) were classified as smokers 
because they smoked cigarettes during the follow-up eriod, 
whereas 468 (60%) were classified as nonsmokers. At base- 
line, smokers had more prior myocrrrdial nfarctions,, more 
activity limitation, more nitrate and less diuretic use and 
were more likely to be nonwhite. Other baseline character- 
istics such as age, gender, hy~ercholestero~emia, his&or? of 
diabetes, number of diseased vessels, ejection fraction, left 
ventricular score, left ventricular end-diastolic pressure, 
amount of angina, employment s atus and use of other 
medications were not significantly different. Of the patients 
who smoked after entry, 99% had smoked previously; ofthe 
nonsmokers, 73% reported smoking before ntry into CASS 
(p < 0.0001). 
‘Qf the baseline variables li ted in Table 1, none differed 
significantly among patients randomized tomedic 
gical therapy (12) or between baseline smokers who quit or 
contiaaed cigarette smoking after entry (
e At the time of this re 
patients had died. Amo 
patients, the average duration of 4Uow-up was 11.2 years 
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Percent Survival 
100 
60 
a0 
1:: 
0 2 4 6 0 10 
Years of Followup 
PIgarc 1. Ten&year survival among all randomized patients. Sur- 
vival among nonsmokers (eirrrles, n = 468) was greater tha,, tinrnn~ 
smokers (triangles, n = 312) at IO-year follow-up (82% vs. 77%). 
(range 9 to 13.2). Two patients were lost to f llow-up after 
4.5 and 10.5 years, respectively. During the initial 10 years of 
follow-up, bypass urgery was performed one or more times 
in 92% of the 390 patients originally assigned tosurgery and 
in 37% of the 390 patients originally assigned to medical 
therapy. 
Cholesterol levels. At the 5-year follow-up study, choles- 
terol evels were obtained in 356 patients (47% of smokers 
and 45% of nonsmokers). Serum cLolestem1 1250 mgldl was 
present in 47% of smokers and 32% of nonsmokers (p = 
0.006). Accordingly, serum cholesterol levels were included 
as covariates in the Cox survival analyses ( ee earlier). 
Survival (Fig. I to 4). Among the 780 randomized pa- 
tients, survival at IO-year follow-up was 82% among those 
who smoked uring follow-up and 77% among those who did 
not smoke (p = 0.025) (Fig. I). Of 284 patients who smoked 
at entry and who could be classified atthe &month follow-up 
as “quitters” or “nonquitters,” survival at IO years was 
significantly higher among quitters (80% versus 69%, p = 
Figure 2. Ten-year survival among patients smoking at study entry. 
Patients who quit smoking (triangles, n = 97) had a higher rate of 
survival (80%) than did the nonquitters (circles, n = 187) (69%) at 10 
years after entry, 
PWcWlt SunrlWl 
I- I 
100 
60 
x9 
or ) 
0 2 4 6 a 10 
Yearn of Follow-up 
0 2 4 6 
Years of Follow.up 
6 10 
Figure 3. Ten-year survival in patients assigne 
There was no statistically significant difference in survival between 
persons who quit (iriangies, n = 44) or did mot q&t (&&es, n= 101) 
smoking. 
0.025) (Fig. 2). Among patients randomized to medical 
therapy, the difference in IO-year strrvival was not signifi- 
cantly different between quitters (75%) and ~o~quitters 
(7i%j (Fig. 3), but in patients randomized to surgery, sur- 
vival at 10 years was considerably higher in quitters than in 
nonquitters (84% vs. 68%, p = 0.018) (Fig. 4). 
The time-dependent Cox survival nalysis demonstrated 
that he amount of time during follow-up a patien 
and the average number of cigarettes/day smoked 
highly significantly correlated with survival (p < 
p = 0.003, respectively). When both “percent 
smoking” and “average daily cigarette consumption” were 
in the Cox survival odel, only “percent of ti 
was significant (p = O.OOS), indicating that the cumulative 
time a patient smokes may be more important than the daily 
quantity smoked. Smoking during 50% and 100% of the 
follow-up interval increased the relative risk of death by 1.56 
and 1.73, respectively. 
Figure 4. Ten-year su vival in patients a signed to surgica! therapy. 
Among patients who were randomized to coronary b pass urgery, 
those who quit rmoking (Lriangles, n =53) had improved suAval 
over that of nonquitters (r&&s, n = 86). 
Percent Sunrival 
I 
2 4 6 6 10 
Years of Follow-up 
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Sm Rlon-8m Sm RIci4-sm 
aseline 
risen with smokers ( 
patients with class I or 11 angina; 
patients with no angina. 
tween smokers and ~~~smo~ers. At IO years, 42% of smok- 
had no angina, 32% had class I or I1 angina, 8% had class 
or 1V angina ana 17% had died, whereas, among the 
angina, 30% had class I or 
angina nd 11% .were dead 
ne in 14%, intermitt 
34%, moderate osevere in 52%) than did nonsmokers (none 
in 19%, intermittent to mild in 3?%, moderate  
42%) (p = 0.015). At the IO-yex fo!?cw+p, tk, e 
activity levels had increased between s 
6. Activity limitation in smokers and nonsmokers. Less 
severe activity limitation was noted both at baseline and at IO-year 
follow-up in nonsmokers (Non-sm) than in smokers (Sm). 
ars = patients who disd; bars = patients with moderate to 
severe activity limitation; crmsl~tched bars = patients with inter- 
mittent or mild activity hmitation; Uask. bars = patients with no 
activity limitation. 
Percent of Patients 
loo - 
60- 
60- 
40 - 
20 
t 
OL 
Sm Non-Sm Sm NonSm 
Baseline 10 Years 
1 2 3 4 5 6 7 6 9 IO 
Years Of iwow-up 
ber of bos~ita~~zatio~s in smokers and 
okers. Over the -year follow-up, the mean number of 
alizations per patient was greater a ong smokers ~~~~~~~~es~ 
II = Jii) than among rioasmo ers (circles, n = 468). 
Smokers had an avera 
ore t~e~ue~tly than were nom 
farction, chest pain, stroke, cardiac cat~eter~~atio~ nd 
peripheral vascular surgery, ht cot more fre~~e~t~~~ for 
heart failure, arrhytk ias or -coronary artery by 
issions for both nonca 
ospitalizations for Smokers and Nonsmokers During 
the IO-Year hollow-Up Feriod 
SfllOkWS Nonsmokers 
(n = 312) (n = 468) p Value 
Number of hospitalizations 
Noncardiac 478 546 <O.OQOl 
Cardiac 829 8YY <O.OW 
Major reasons for hospitalization* 
Myocardial infarction 84 14 0.0016 
Chest pain 358 269 
Stroke 31 21 
Heart failure 38 64 
Arrhythmias 14 102 0.64 
Caldiac catheterization 154 185 0. 
Coronary alery bypass surgery 235 31.4 0.60 
Peripheral vascular surgery 13 6 0.02 
*Reasons for hospitalizations were verified during the 1st 4 years of 
follow-up by retrieval of hospital charts and afterward by patient interview. 
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Table 3. Medication Use in Smokers and Nonsmokers at lo-Year 
Follow-Up 
Smokers Nonsmoktrs 
NO. % No. % p Value* 
Nitrates 51 26.2 94 29.6 0.47 
Beta-blockers 67 34.4 147 46.2 0.01 
Calcium channel blockers 44 22.9 88 27.9 G.25 
Digitalis 26 13.3 46 14.5 0.82 
Diuretics 56 28.7 86 27 0.76 
*Assessed by Yates corrected chi-square analysis. 
tions were more frequent in smokers than in nonsmokers 
(p < O.OOOl), 
~~~r~~~o~, Ar the IO-year follow-up evaluation, 504 
patnl;ieuris had uadcrgone ~~omrary llcry b;jp~s surgei’y UK-I 
236 patients had received only medical ireatmenl. 4rrons 
those patients initially in the medical group who later undsr- 
went bypass urgery, 66 were smoke rs and 78 were non- 
smokers (p = 0.26), Among patierrts who underwene a 
coronary bypass procedure and srr.tiked uring follow-up 
(n = 209), 25 (12.1%) required repeat coronary artery bypass 
surgery, whereas among patients who underwent bypass 
surgery but did not smoke during follow-up (n = 299), 25 
(8.4%) required a second bypass procedure (p= 0.18). The 
average l ngth of time from the first to the second bypass 
procedure in smokers and nonsmokers did not differ signif- 
icantly. 
Use of medication (Table 3). There were no differences in 
the use of nitrates, digitalis or diuretic drugs between on- 
smokers and smokers during the IO-year follow-up eriod. 
Calcium channel blockers were not commercially available 
during the initial CASS follow-up evaluation, but there was 
no difference in their use by smokers and nonsmokers at the 
lo-year evaluation. However, beta-adrenergic blocking 
agents were more commonly prescribed in nonsmokers than 
in smokers from the 5th through the 10th year of follow-up. 
Nevertheless, the Cox proportional hazards analysis, which 
adjusted for beta-blocker usage, showed the diZerence in
survival between smoking and nonsmoking patients to be 
independent of treatment with a beta-blocking drug. 
~~loy~e~~. At enrry int:, the study, 93% of smokers 
and 68% of nonsmokers were employed (p = 0.15). At 
follow-up years 1,3,5 and 10 the percent employed among 
smokers and nonsmokers was 69% versus 64% (p = O.Ol), 
60% versus 55% (p = 0.009), 53% versus 50% (p = 0.09) and 
39% versus 32% (p = O.lO), respectively; the remaining 
patients were unemployed or dead. 
The impact of smoking on th care costs, The per diem 
cost of a day in a U.S. hospital in 1988 was $538.% (ll), 
exclusive of professional fees. Smokers had an verage of
8.8 additional hospital days compared with nonsmokers fora 
minimai estimated additional hospital care expenditure of 
$4,742.85/smoker during the 10 years. Smoking patients 
consumed a mean of 14.5 cigarettes/day (52,925 cigarettes 
during the IO-year follow-up period). Therefore, the esti- 
mated additional hospital expense per cigarette smoked 
during fhe follow-up eriod was $0.09, or $1.8 
This study shows that continued cigarette smoking in 
patients with angiographically documented coronary artery 
disease adversely affects survi.val, especially in thos 
subsequently lmdergo coronary bypass graft surgery. 
over, patients who continue to smoke during the next 10 
years have more angina, activity limitation, 
hospital dmissions (for bot iac and ~~~~ardia~ c 
ruons), more strokes and more surgery for peripbera~ vascu- 
lar disease than do their counterparts who do not smoke. 
The observation ihat smokers do sot live as long as 
~o~srn~k~~s is not new and hds been retorted in many 
epidemiologic stlldies IA, 13JR) in which the increased mm- 
ber of deaths was due to myocardial i~far~t~o~~ and sudden 
death. Previous studies (5,17) in general populations have 
shown that smoking cessation resuhs in an improved sur- 
vivai and decreased incidence of myocardial infarction. 
Recent reports from the CASS registry (6.9) have shower that 
smoking cessation also improves urvival in patients who 
have angiographically documented coronary artery disease, 
including patients who are elderly (7). In the present study, 
patients with coronary artery disease were randomized 
either to continued medical treatment orto coronary artery 
bypass urgery, allowing the unique opportunity o analyze 
the differential effect of smoking on survival in subgroups of 
patients reated medically or surgically. 
Survival in patient raadQm~ed to medical or SW 
treatment according tosmoking status. Among randomized 
patients inCASS, survival was gher among those who did 
not smoke during follow-up. oreover, in palients who 
smoked at entry into the study, survival was higher among 
those who stopped smoking. The difference in survival 
between quitters and nonquitters did not reach statistical 
significance in the subgroup ofpatients randomized tomed- 
ical therapy. However, among smokers randomized to by- 
pass surgery, survival was significantly higher in quitters 
than in nonquitters, raising the possibility that: continued 
smoking has a more deleterious effect on survival inpatients 
undergoing coronary bypass grafting than on those continu- 
ing on medical therapy. There are several potential explana- 
tions for this observation. 
First, smoking may have contribuled to accelerated de- 
terioration ofbypass grafts in some patients. Smoking has 
been shown to play a role in the late thrombosis of saphen- 
ous vein grafts (19). Follow-up angiography after coronary 
artery bypass surgery has revealed a greater proportion of 
diseased oroccluded grafts in smokers (20). 
Second, intensified pharmacologic therapy in the medi- 
cally assigned patients may have masked the deleterious 
effects of smoking. Beta-blocker and nitrate usage in the 
medically assigned patients exceeded that of the surgically 
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ers. 
Finally, the failure to 
IO-year survival betwee 
nonsmokers may repres 
year follow-up da.a from the (~onra~do~~~~ed~ CASS regis- t 
complicated because, in m y patients, ~~ok~~~ behavior 
varies over time. Thus, if ior at an arbitrary 
follow-up iime is used t seline smokers as 
“quitters” or ~‘no~~u~tters,” the following 
result: 1) those smokers who exhibit “mixe 
havior” (nonquitters who stopped smoking later in the study 
or quitters wbo resumed smoking) may be misclassified, an
2) the amount of smoking (e.g., Vz pack versus 2 packs of 
cigarettes/day) is not considered. To avoid these problems, a 
time-dependent Cox analysis was Reformed and confirmed 
the increased risk of death during follow-up among smokers. 
A significantly increased risk of premature d ath was found 
for each cigarett;/day smoked. The percent of time that a 
person smoked uring follow-up seemed even more impor- 
tant han the number of cigarettes smoked, suggesting that, 
although there is measurable b nefit n reducing the number 
of cigarettes smoked each day, an even greater benefit is 
achieved by stopping smoking, which ultimately reduces the 
duration of rime that a patient has smoked. Previous work 
has reported a relation between increased cardiovascular 
risks and increased aily smoking constrmption (23) and 
suggested that the duration of time smoking was even more 
significant than the quantity of cigarettes smoked (244). 
Smoking and extent of angina nd activity ~~rni~~~~~. In 
the past, no association between smoking and increased 
angina pectoris (23,25) has been noted. In CASS only 
patients without angina after myocardial infarction or with 
class I to II angina were enrolled. During the IO-year 
follow-up, smokers had more angina and more activity 
limitation than did nonsmokers. 
~S~i~~i~~tiQ~~~ The frequency of hospital admissions 
was greater in the smokers than nonsmokers over the 
IO-year follow-up eriod, a findi lg that would be expected to
be attributable to the higher incidence of pulmonary dys- 
function associated with smoking. Although admissions for 
noncar&x causes were indeed more common in smokers 
than in nonsmokers, admissions for car&m muses (chest 
pain, myocardial infarction and cardiac catheterization, but
health care were collected i? CASS, an 
smoke cigarettes incur an increa 
least $1 .Wpack. This estimate 
professional fees, the additio 
required because ofpulmonary dis;ease or
reflect lost wages or employer II
CASS shows sig~~fi~a~t dBerences inwr- 
Gal and morbidity in patients with giographically docu- 
i2ented coronary x!ei-- nding on smoking 
behavior. Smoking behavi ndomized in CASS 
and the current study is observational in nature, with all i%c 
attendant limitations of such studies. owever. it would 
probably be impossible to perform a tria 
ers to continued smoking or smoking cessation because of 
ethical and p reports (27-30) 
that directly hysiology begin 
to elucidate mechanisms whereby tobacco use inflicts 
cardiac mortality and morbidity. Our data strongly im 
that patients with coronary artery disease should be encour- 
aged to stop smoking to improve survival and ecrease 
cardiac morbidity. Inaddition, patients undergoing coronary 
artery bypass surgery should be informed that he survival 
benefit of the operation may be substantially attenuated by 
continued smoking. 
We gratefully acknowledge the expert assistance of Lori Parsons in the 
statistical data analysis and the insight provided by Edgar D. Charles, PhD in 
the cost analysis. 
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